US3977794A
(en)
|
1974-07-15 |
1976-08-31 |
Coulter Electronics, Inc. |
Universal cell holder
|
DE2650306A1
(en)
|
1976-11-02 |
1978-05-03 |
Merck Patent Gmbh |
ANTIBACTERIAL DRESSING AND METHOD OF ITS MANUFACTURING
|
US4270537A
(en)
|
1979-11-19 |
1981-06-02 |
Romaine Richard A |
Automatic hypodermic syringe
|
US4316885A
(en)
|
1980-08-25 |
1982-02-23 |
Ayerst, Mckenna And Harrison, Inc. |
Acyl derivatives of rapamycin
|
DE3260468D1
(en)
|
1981-01-09 |
1984-09-06 |
Sandoz Ag |
Novel cyclosporins
|
US4894366A
(en)
|
1984-12-03 |
1990-01-16 |
Fujisawa Pharmaceutical Company, Ltd. |
Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
|
US5254562A
(en)
|
1984-12-03 |
1993-10-19 |
Fujisawa Pharmaceutical Company, Ltd. |
Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
|
US4596556A
(en)
|
1985-03-25 |
1986-06-24 |
Bioject, Inc. |
Hypodermic injection apparatus
|
USD296006S
(en)
|
1985-06-20 |
1988-05-31 |
Ciba-Geigy Corporation |
Multicompartmentalized transdermal patch for administering drugs to the skin
|
US4650803A
(en)
|
1985-12-06 |
1987-03-17 |
University Of Kansas |
Prodrugs of rapamycin
|
US4886499A
(en)
|
1986-12-18 |
1989-12-12 |
Hoffmann-La Roche Inc. |
Portable injection appliance
|
GB8704027D0
(en)
|
1987-02-20 |
1987-03-25 |
Owen Mumford Ltd |
Syringe needle combination
|
US4798823A
(en)
|
1987-06-03 |
1989-01-17 |
Merck & Co., Inc. |
New cyclosporin analogs with modified "C-9 amino acids"
|
US4941880A
(en)
|
1987-06-19 |
1990-07-17 |
Bioject, Inc. |
Pre-filled ampule and non-invasive hypodermic injection device assembly
|
US4940460A
(en)
|
1987-06-19 |
1990-07-10 |
Bioject, Inc. |
Patient-fillable and non-invasive hypodermic injection device assembly
|
US4790824A
(en)
|
1987-06-19 |
1988-12-13 |
Bioject, Inc. |
Non-invasive hypodermic injection device
|
US5227467A
(en)
|
1987-08-03 |
1993-07-13 |
Merck & Co., Inc. |
Immunosuppressive fluorinated cyclosporin analogs
|
US5339163A
(en)
|
1988-03-16 |
1994-08-16 |
Canon Kabushiki Kaisha |
Automatic exposure control device using plural image plane detection areas
|
FR2638359A1
(en)
|
1988-11-03 |
1990-05-04 |
Tino Dalto |
SYRINGE GUIDE WITH ADJUSTMENT OF DEPTH DEPTH OF NEEDLE IN SKIN
|
US5008110A
(en)
|
1988-11-10 |
1991-04-16 |
The Procter & Gamble Company |
Storage-stable transdermal patch
|
US5284826A
(en)
|
1989-07-24 |
1994-02-08 |
Sandoz Ltd. |
0-hydroxyethyl and acyloxyethyl derivatives of [ser]8 cyclosporins
|
US5312335A
(en)
|
1989-11-09 |
1994-05-17 |
Bioject Inc. |
Needleless hypodermic injection device
|
US5064413A
(en)
|
1989-11-09 |
1991-11-12 |
Bioject, Inc. |
Needleless hypodermic injection device
|
US5208228A
(en)
|
1989-11-13 |
1993-05-04 |
Merck & Co., Inc. |
Aminomacrolides and derivatives having immunosuppressive activity
|
US5225194A
(en)
*
|
1989-11-13 |
1993-07-06 |
Ldc Research Corporation |
Aqueous diafiltration process for preparing acellular vaccines, against selected bacterial diseases
|
US5122511A
(en)
|
1990-02-27 |
1992-06-16 |
Merck & Co., Inc. |
Immunosuppressive cyclosporin analogs with modified amino acids at position-8
|
US5190521A
(en)
|
1990-08-22 |
1993-03-02 |
Tecnol Medical Products, Inc. |
Apparatus and method for raising a skin wheal and anesthetizing skin
|
PT98990A
(en)
|
1990-09-19 |
1992-08-31 |
American Home Prod |
PROCESS FOR THE PREPARATION OF CARBOXYLIC ACID ESTERS OF RAPAMICIN
|
US5143918A
(en)
|
1990-10-11 |
1992-09-01 |
Merck & Co., Inc. |
Halomacrolides and derivatives having immunosuppressive activity
|
US5527288A
(en)
|
1990-12-13 |
1996-06-18 |
Elan Medical Technologies Limited |
Intradermal drug delivery device and method for intradermal delivery of drugs
|
US5120842A
(en)
|
1991-04-01 |
1992-06-09 |
American Home Products Corporation |
Silyl ethers of rapamycin
|
US5100883A
(en)
|
1991-04-08 |
1992-03-31 |
American Home Products Corporation |
Fluorinated esters of rapamycin
|
US5118678A
(en)
|
1991-04-17 |
1992-06-02 |
American Home Products Corporation |
Carbamates of rapamycin
|
US5262533A
(en)
|
1991-05-13 |
1993-11-16 |
Merck & Co., Inc. |
Amino O-aryl macrolides having immunosuppressive activity
|
US5565560A
(en)
|
1991-05-13 |
1996-10-15 |
Merck & Co., Inc. |
O-Aryl,O-alkyl,O-alkenyl and O-alkynylmacrolides having immunosuppressive activity
|
US5250678A
(en)
|
1991-05-13 |
1993-10-05 |
Merck & Co., Inc. |
O-aryl, O-alkyl, O-alkenyl and O-alkynylmacrolides having immunosuppressive activity
|
US5162334A
(en)
|
1991-05-13 |
1992-11-10 |
Merck & Co., Inc. |
Amino O-alkyl, O-alkenyl and O-alkynlmacrolides having immunosuppressive activity
|
US5120727A
(en)
|
1991-05-29 |
1992-06-09 |
American Home Products Corporation |
Rapamycin dimers
|
US5120725A
(en)
|
1991-05-29 |
1992-06-09 |
American Home Products Corporation |
Bicyclic rapamycins
|
US5169851A
(en)
|
1991-08-07 |
1992-12-08 |
American Home Products Corporation |
Rapamycin analog as immunosuppressants and antifungals
|
US5202332A
(en)
|
1991-08-07 |
1993-04-13 |
American Home Products Corporation |
Rapamycin analog as immunosuppressant
|
US5189042A
(en)
|
1991-08-22 |
1993-02-23 |
Merck & Co. Inc. |
Fluoromacrolides having immunosuppressive activity
|
GB9118204D0
(en)
|
1991-08-23 |
1991-10-09 |
Weston Terence E |
Needle-less injector
|
US5208241A
(en)
|
1991-09-09 |
1993-05-04 |
Merck & Co., Inc. |
N-heteroaryl, n-alkylheteroaryl, n-alkenylheteroaryl and n-alkynylheteroarylmacrolides having immunosuppressive activity
|
SE9102652D0
(en)
|
1991-09-13 |
1991-09-13 |
Kabi Pharmacia Ab |
INJECTION NEEDLE ARRANGEMENT
|
US5151413A
(en)
|
1991-11-06 |
1992-09-29 |
American Home Products Corporation |
Rapamycin acetals as immunosuppressant and antifungal agents
|
US6911220B1
(en)
|
1992-02-19 |
2005-06-28 |
The General Hospital Corporation |
Allogeneic and xenogeneic transplantation
|
US5328483A
(en)
|
1992-02-27 |
1994-07-12 |
Jacoby Richard M |
Intradermal injection device with medication and needle guard
|
US6010715A
(en)
|
1992-04-01 |
2000-01-04 |
Bertek, Inc. |
Transdermal patch incorporating a polymer film incorporated with an active agent
|
US5284840A
(en)
|
1992-06-12 |
1994-02-08 |
Merck & Co., Inc. |
Alkylidene macrolides having immunosuppressive activity
|
US5383851A
(en)
|
1992-07-24 |
1995-01-24 |
Bioject Inc. |
Needleless hypodermic injection device
|
US5569189A
(en)
|
1992-09-28 |
1996-10-29 |
Equidyne Systems, Inc. |
hypodermic jet injector
|
US5334144A
(en)
|
1992-10-30 |
1994-08-02 |
Becton, Dickinson And Company |
Single use disposable needleless injector
|
US5258389A
(en)
|
1992-11-09 |
1993-11-02 |
Merck & Co., Inc. |
O-aryl, O-alkyl, O-alkenyl and O-alkynylrapamycin derivatives
|
US5558869A
(en)
|
1992-12-30 |
1996-09-24 |
University Of Arkansas |
Major peanut allergen ara h II
|
US5591767A
(en)
|
1993-01-25 |
1997-01-07 |
Pharmetrix Corporation |
Liquid reservoir transdermal patch for the administration of ketorolac
|
US5504091A
(en)
|
1993-04-23 |
1996-04-02 |
American Home Products Corporation |
Biotin esters of rapamycin
|
US5543158A
(en)
|
1993-07-23 |
1996-08-06 |
Massachusetts Institute Of Technology |
Biodegradable injectable nanoparticles
|
JPH09504308A
(en)
|
1993-07-23 |
1997-04-28 |
マサチューセッツ インスティチュート オブ テクノロジー |
Non-linear hydrophilic-hydrophobic multiblock copolymer nanoparticles and microparticles
|
US5565215A
(en)
|
1993-07-23 |
1996-10-15 |
Massachusettes Institute Of Technology |
Biodegradable injectable particles for imaging
|
US5830877A
(en)
|
1993-08-26 |
1998-11-03 |
The Regents Of The University Of California |
Method, compositions and devices for administration of naked polynucleotides which encode antigens and immunostimulatory
|
IT1261849B
(en)
|
1993-09-02 |
1996-06-03 |
Avantgarde Spa |
MEDICAL DEVICE FOR THE ADMINISTRATION OF ACTIVE INGREDIENTS OR VERY LOW DOSAGE DRUGS, IN PARTICULAR HOMEOPATHIC DRUGS.
|
WO1995024176A1
(en)
|
1994-03-07 |
1995-09-14 |
Bioject, Inc. |
Ampule filling device
|
US5466220A
(en)
|
1994-03-08 |
1995-11-14 |
Bioject, Inc. |
Drug vial mixing and transfer device
|
CA2194761C
(en)
|
1994-07-15 |
2006-12-19 |
Arthur M. Krieg |
Immunomodulatory oligonucleotides
|
US6207646B1
(en)
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
US6007845A
(en)
|
1994-07-22 |
1999-12-28 |
Massachusetts Institute Of Technology |
Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers
|
US5837533A
(en)
|
1994-09-28 |
1998-11-17 |
American Home Products Corporation |
Complexes comprising a nucleic acid bound to a cationic polyamine having an endosome disruption agent
|
US5693648A
(en)
|
1994-09-30 |
1997-12-02 |
Merck & Co., Inc. |
O-aryl, O-alkyl, O-alkenyl and O-alkynyl-macrolides having immunosuppressive activity
|
US5660854A
(en)
|
1994-11-28 |
1997-08-26 |
Haynes; Duncan H |
Drug releasing surgical implant or dressing material
|
WO1996020698A2
(en)
|
1995-01-05 |
1996-07-11 |
The Board Of Regents Acting For And On Behalf Of The University Of Michigan |
Surface-modified nanoparticles and method of making and using same
|
US5599302A
(en)
|
1995-01-09 |
1997-02-04 |
Medi-Ject Corporation |
Medical injection system and method, gas spring thereof and launching device using gas spring
|
US6126936A
(en)
|
1995-03-10 |
2000-10-03 |
Biohybrid Technologies Llc |
Microcapsules and composite microreactors for immunoisolation of cells
|
KR100201352B1
(en)
|
1995-03-16 |
1999-06-15 |
성재갑 |
Single shot vaccine formulation
|
US5730723A
(en)
|
1995-10-10 |
1998-03-24 |
Visionary Medical Products Corporation, Inc. |
Gas pressured needle-less injection device and method
|
ES2177592T3
(en)
|
1995-07-05 |
2002-12-16 |
Europ Economic Community |
BIOCOMPATIBLE AND BIODEGRADABLE NANOPARTICLES FOR THE ABSORPTION AND ADMINISTRATION OF PROTEINIC MEDICINES.
|
DE19537012A1
(en)
|
1995-10-04 |
1997-04-10 |
Dietl Hans |
Pharmaceutical preparation containing cyclosporin (s) for oral administration and process for its preparation
|
AU729836B2
(en)
|
1995-12-29 |
2001-02-08 |
University Of Arkansas, The |
Peanut allergens and methods
|
US20030202980A1
(en)
|
1995-12-29 |
2003-10-30 |
Caplan Michael J. |
Methods and reagents for decreasing clinical reaction to allergy
|
US6835824B1
(en)
|
1995-12-29 |
2004-12-28 |
University Of Arkansas |
Peanut allergens and methods
|
US5893397A
(en)
|
1996-01-12 |
1999-04-13 |
Bioject Inc. |
Medication vial/syringe liquid-transfer apparatus
|
GB9607549D0
(en)
|
1996-04-11 |
1996-06-12 |
Weston Medical Ltd |
Spring-powered dispensing device
|
AU734665B2
(en)
|
1996-05-09 |
2001-06-21 |
General Hospital Corporation, The |
Mixed chimerism and tolerance
|
US5739432A
(en)
|
1996-05-30 |
1998-04-14 |
The Regents Of The University Of California |
Ultrasonic characterization of single drops of liquids
|
US5709797A
(en)
|
1996-06-05 |
1998-01-20 |
Poli Industria Chimica S.P.A. |
Method of isolating cyclosporins
|
US5774209A
(en)
|
1996-10-08 |
1998-06-30 |
Spectronic Instruments, Inc. |
Transmittance cell for spectrophotometer
|
ATE292980T1
(en)
|
1996-10-11 |
2005-04-15 |
Univ California |
IMMUNO-STIMULATING OLIGONUCLEOTIDE CONJUGATES
|
ATE441432T1
(en)
|
1997-03-10 |
2009-09-15 |
Ottawa Hospital Res Inst |
USE OF NON-METHYLATED CPG DINUCLEOTIDE IN COMBINATION WITH ALUMINUM AS ADJUVANTS
|
WO1998048859A1
(en)
*
|
1997-04-30 |
1998-11-05 |
Guilford Pharmaceuticals Inc. |
Biodegradable compositions comprising poly(cycloaliphatic phosphoester) compounds, articles, and methods for using the same
|
US5993412A
(en)
|
1997-05-19 |
1999-11-30 |
Bioject, Inc. |
Injection apparatus
|
US5948433A
(en)
|
1997-08-21 |
1999-09-07 |
Bertek, Inc. |
Transdermal patch
|
US6342507B1
(en)
|
1997-09-05 |
2002-01-29 |
Isotechnika, Inc. |
Deuterated rapamycin compounds, method and uses thereof
|
US7399480B2
(en)
|
1997-09-26 |
2008-07-15 |
Abbott Laboratories |
Methods of administering tetrazole-containing rapamycin analogs with other therapeutic substances using medical devices
|
ATE423130T1
(en)
|
1997-10-08 |
2009-03-15 |
Isotechnika Inc |
DEUTERATED CYCLOSPORINE ANALOGS AND THEIR USE AS IMMUNOMODULATING AGENTS
|
IT1298087B1
(en)
|
1998-01-08 |
1999-12-20 |
Fiderm S R L |
DEVICE FOR CHECKING THE PENETRATION DEPTH OF A NEEDLE, IN PARTICULAR APPLICABLE TO A SYRINGE FOR INJECTIONS
|
DE69921773D1
(en)
|
1998-01-16 |
2004-12-16 |
Univ Johns Hopkins |
ORAL ADMINISTRATION OF NUCLEIC ACID VACCINE THROUGH PARTICLE COMPLEXES
|
US6238925B1
(en)
|
1998-01-30 |
2001-05-29 |
Panacea Pharmaceuticals, Llc |
Method for determining likelihood of developing clinical tolerance
|
DE69940805D1
(en)
|
1998-01-31 |
2009-06-10 |
Sinai School Medicine |
METHOD AND REAGENTS FOR REDUCING THE CLINICAL REACTION TO ALLERGY
|
US7879977B2
(en)
|
1998-01-31 |
2011-02-01 |
University Of Arkansas |
Methods and reagents for decreasing clinical reaction to allergy
|
US5965154A
(en)
|
1998-03-17 |
1999-10-12 |
Plc Holding, L.L.C. |
Adhesive matrix type transdermal patch and method of manufacturing same
|
SE9801288D0
(en)
|
1998-04-14 |
1998-04-14 |
Astra Ab |
Vaccine delivery system and method of production
|
US6299875B1
(en)
|
1998-06-04 |
2001-10-09 |
Panacea Pharmaceuticals, Llc |
Methods to block IGE binding to cell surface receptors of mast cells
|
ATE428371T1
(en)
|
1998-07-17 |
2009-05-15 |
Pacira Pharmaceuticals Inc |
BIODEGRADABLE ARRANGEMENTS FOR THE CONTROLLED RELEASE OF ENCLOSED SUBSTANCES
|
FR2785812B1
(en)
|
1998-11-16 |
2002-11-29 |
Commissariat Energie Atomique |
BIOACTIVE PROSTHESES, IN PARTICULAR WITH IMMUNOSUPPRESSIVE PROPERTIES, ANTISTENOSIS AND ANTITHROMBOSIS, AND THEIR MANUFACTURE
|
US6551990B2
(en)
|
1998-12-07 |
2003-04-22 |
University Of Washington |
Methods of inhibiting ectopic calcification
|
AU2196500A
(en)
|
1998-12-18 |
2000-07-03 |
Michael Caplan |
Methods and compositions for decreasing allergic reactions to surface allergens
|
WO2000037067A2
(en)
|
1998-12-22 |
2000-06-29 |
Panacea Pharmaceuticals, Llc |
Sensitizing agents for the treatment of skin lesions
|
US20020009452A1
(en)
|
1999-02-10 |
2002-01-24 |
Michael Caplan |
Method for altering undesirable immune responses to polypeptides
|
WO2000054803A2
(en)
|
1999-03-16 |
2000-09-21 |
Panacea Pharmaceuticals, Llc |
Immunostimulatory nucleic acids and antigens
|
US20020090381A1
(en)
|
1999-04-09 |
2002-07-11 |
H. Kim Bottomly |
System for controlling immune system response to antigen
|
WO2001014855A1
(en)
|
1999-08-20 |
2001-03-01 |
Charles William Robertson |
Liquid photometer using surface tension to contain sample
|
AU4139801A
(en)
|
1999-12-06 |
2001-06-12 |
Board Of Trustees Of The University Of Arkansas, The |
Controlled delivery of antigens
|
US8246945B2
(en)
|
2000-04-06 |
2012-08-21 |
University Of Arkansas |
Methods and reagents for decreasing clinical reaction to allergy
|
CA2403292C
(en)
|
2000-04-06 |
2011-02-08 |
Panacea Pharmaceuticals, Llc |
Microbial delivery system
|
EP1292285A4
(en)
|
2000-06-02 |
2009-07-22 |
Eisai Corp North America |
Delivery systems for bioactive agents
|
US7182933B2
(en)
|
2000-10-12 |
2007-02-27 |
The University Of Tennessee Research Corporation |
Targeting drug/gene carriers to irradiated tissue
|
US6676963B1
(en)
|
2000-10-27 |
2004-01-13 |
Barnes-Jewish Hospital |
Ligand-targeted emulsions carrying bioactive agents
|
US6544543B1
(en)
|
2000-12-27 |
2003-04-08 |
Advanced Cardiovascular Systems, Inc. |
Periodic constriction of vessels to treat ischemic tissue
|
US6809826B2
(en)
|
2001-02-20 |
2004-10-26 |
Charles William Robertson |
Liquid photometer using surface tension to contain sample
|
AU2002233619A1
(en)
|
2001-02-26 |
2002-09-12 |
Zur Pierre Beserman |
Systems devices and methods for intrabody targeted delivery and reloading of therapeutic agents
|
EP1379227A4
(en)
|
2001-03-21 |
2007-12-12 |
Univ Kentucky Res Found |
Microemulsions as precursors to solid nanoparticles
|
US20030153044A1
(en)
|
2001-05-14 |
2003-08-14 |
Monika Liljedahl |
Tissues or organs for use in xenotransplantation
|
US20030003591A1
(en)
|
2001-07-02 |
2003-01-02 |
Ortho-Clinical Diagnostics, Inc. |
Reaction vessel
|
US7081489B2
(en)
|
2001-08-09 |
2006-07-25 |
Florida State University Research Foundation |
Polymeric encapsulation of nanoparticles
|
US20040023897A1
(en)
|
2001-11-13 |
2004-02-05 |
Caplan Michael J. |
Methods for preventing or treating disease mediated by toxin-secreting bacteria
|
WO2003048298A2
(en)
|
2001-12-05 |
2003-06-12 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Nanoparticles containing polymeric nucleic acid homologs, pharmaceutical compositions and articles of manufacture containing same and methods of use thereof
|
US20030235619A1
(en)
|
2001-12-21 |
2003-12-25 |
Christine Allen |
Polymer-lipid delivery vehicles
|
US20040038303A1
(en)
|
2002-04-08 |
2004-02-26 |
Unger Gretchen M. |
Biologic modulations with nanoparticles
|
US7285289B2
(en)
|
2002-04-12 |
2007-10-23 |
Nagy Jon O |
Nanoparticle vaccines
|
WO2004064751A2
(en)
|
2003-01-16 |
2004-08-05 |
St. Johns University New York |
Nanoparticle based stabilization of ir fluorescent dyes
|
ATE371437T1
(en)
|
2003-02-17 |
2007-09-15 |
Peter Burkhard |
PEPTIDIC NANOPARTICLES AS DRUG DELIVERY AND ANTIGEN DISPLAY SYSTEMS
|
CN1875101A
(en)
|
2003-09-02 |
2006-12-06 |
北卡罗来纳-查佩尔山大学 |
Biodegradable polymer-ligand conjugates and their uses in isolation of cellular subpolulations and in cryopreservation, culture and transplantation of cells
|
ES2246695B1
(en)
*
|
2004-04-29 |
2007-05-01 |
Instituto Cientifico Y Tecnologico De Navarra, S.A. |
STIMULATING COMPOSITION OF THE IMMUNE RESPONSE THAT INCLUDES NANOPARTICLES BASED ON A COPYLIMER OF METHYL VINYL ETER AND MALEIC ANHYDRIDE.
|
US20080260851A1
(en)
|
2004-05-13 |
2008-10-23 |
The Trustees Of Columbia University In The City Of New York |
Polymeric Nanoparticles and Nanogels for Extraction and Release of Compounds
|
CA2571899A1
(en)
|
2004-07-01 |
2006-08-03 |
Yale University |
Targeted and high density drug loaded polymeric materials
|
US9079765B2
(en)
|
2004-10-01 |
2015-07-14 |
Midatech Ltd. |
Nanoparticles comprising antigens and adjuvants, and immunogenic structures
|
US7375815B2
(en)
|
2004-10-12 |
2008-05-20 |
Agilent Technologies, Inc. |
Optical devices, systems and method for producing a collimated light path
|
US20060087650A1
(en)
|
2004-10-21 |
2006-04-27 |
Shen Thomas Y |
Cuvette holder for spectrophotometers
|
US20060109468A1
(en)
|
2004-11-24 |
2006-05-25 |
Evans Richard W |
Devices, methods, and systems for measuring an optical property of a sample
|
US20100128265A1
(en)
|
2005-02-11 |
2010-05-27 |
Nanodrop Technologies, Inc. |
Apparatus and method for measuring the signal from a fluorescing nanodrop contained by surface tension
|
EP1716847B1
(en)
|
2005-04-28 |
2008-01-02 |
Nipro Corporation |
Bioabsorbable pharmaceutical formulation comprising a PLGA copolymer
|
CA2605551A1
(en)
|
2005-05-10 |
2006-11-16 |
Naomi Balaban |
Compositions for administering rnaiii-inhibiting peptides
|
US8252846B2
(en)
|
2005-05-10 |
2012-08-28 |
Emory University |
Strategies for delivery of active agents using micelles and particles
|
US20070026126A1
(en)
|
2005-08-01 |
2007-02-01 |
Bryan Hitchcock |
Sterol fortified beverages
|
AU2006325225B2
(en)
|
2005-12-14 |
2013-07-04 |
Cytos Biotechnology Ag |
Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity
|
US8021689B2
(en)
|
2006-02-21 |
2011-09-20 |
Ecole Polytechnique Federale de Lausanne (“EPFL”) |
Nanoparticles for immunotherapy
|
US9188594B2
(en)
|
2006-12-06 |
2015-11-17 |
Yale University |
Nanoelectronic-enzyme linked immunosorbent assay system and method
|
US10265407B2
(en)
|
2007-02-15 |
2019-04-23 |
Yale University |
Modular nanodevices for smart adaptable vaccines
|
WO2008115641A2
(en)
|
2007-02-15 |
2008-09-25 |
Yale University |
Modular nanoparticles for adaptable vaccines
|
JP5443175B2
(en)
*
|
2007-02-22 |
2014-03-19 |
バクスター・インターナショナル・インコーポレイテッド |
Method for purifying hydrophobic proteins
|
WO2008109347A2
(en)
|
2007-03-02 |
2008-09-12 |
Yale University |
Methods for ex vivo administration of drugs to grafts using polymeric nanoparticles
|
EP2136788B1
(en)
*
|
2007-03-30 |
2011-10-26 |
Bind Biosciences, Inc. |
Cancer cell targeting using nanoparticles
|
WO2009038591A1
(en)
|
2007-09-17 |
2009-03-26 |
Yale University |
Bile salt colloids and methods of making and using thereof
|
US10736848B2
(en)
*
|
2007-10-12 |
2020-08-11 |
Massachusetts Institute Of Technology |
Vaccine nanotechnology
|
GB0721081D0
(en)
|
2007-10-26 |
2007-12-05 |
Metcalfe Susan M |
Immuno-modulatory composition
|
US8629098B2
(en)
|
2008-01-15 |
2014-01-14 |
Yale University |
Compositions and methods for adoptive and active immunotherapy
|
US9737593B2
(en)
|
2008-03-19 |
2017-08-22 |
Yale University |
Carbon nanotube compositions and methods of use thereof
|
WO2010003009A2
(en)
|
2008-07-01 |
2010-01-07 |
Emory University |
Synergistic induction of humoral and cellular immunity by combinatorial activation of toll-like receptors
|
US20100031262A1
(en)
|
2008-07-31 |
2010-02-04 |
Baird-Gent Jill M |
Program Schedule Sub-Project Network and Calendar Merge
|
US8323696B2
(en)
|
2008-08-29 |
2012-12-04 |
Ecole Polytechnique Federale De Lausanne |
Nanoparticles for immunotherapy
|
US8343498B2
(en)
*
|
2008-10-12 |
2013-01-01 |
Massachusetts Institute Of Technology |
Adjuvant incorporation in immunonanotherapeutics
|
EP3936122A1
(en)
|
2008-11-24 |
2022-01-12 |
Massachusetts Institute Of Technology |
Methods and compositions for localized agent delivery
|
AU2010206854A1
(en)
|
2009-01-20 |
2011-08-04 |
Myelin Repair Foundation, Inc. |
Compositions and methods for induction of antigen-specific tolerance
|
US8822065B2
(en)
|
2009-03-11 |
2014-09-02 |
Samsung Sdi Co., Ltd. |
Rechargeable battery with current collector plate
|
US20120219545A1
(en)
|
2009-07-31 |
2012-08-30 |
Mount Sinai School Of Medicine |
Materials and methods for diagnosing and treating shellfish allergy
|
US8802375B2
(en)
|
2009-09-14 |
2014-08-12 |
Icahn School Of Medicine At Mount Sinai |
Methods for characterizing antibody binding affinity and epitope diversity in food allergy
|
US8727965B2
(en)
|
2010-03-05 |
2014-05-20 |
Tissue Genesis, Inc. |
Methods and compositions to support tissue integration and inosculation of transplanted tissue and transplanted engineered penile tissue with adipose stromal cells
|
WO2011150235A1
(en)
|
2010-05-27 |
2011-12-01 |
Allertein Therapeutics, Llc |
Methods and reagents for treating autoimmune disorders and/or graft rejection
|
CN103118678A
(en)
|
2010-07-16 |
2013-05-22 |
约翰斯·霍普金斯大学 |
Methods and compositions for cancer immunotherapy
|
JP5909745B2
(en)
|
2010-11-12 |
2016-04-27 |
クール ファーマシューティカルズ ディベロップメント カンパニー |
Drugs for inflammatory diseases as well as drugs for viral or bacterial infections
|
WO2012149393A2
(en)
|
2011-04-29 |
2012-11-01 |
Selecta Biosciences, Inc. |
Tolerogenic synthetic nanocarriers for antigen-specific deletion of t effector cells
|
US9446175B2
(en)
|
2011-06-03 |
2016-09-20 |
Yale University |
Compositions and methods for treating and preventing neointimal stenosis
|
US9326951B2
(en)
|
2011-06-28 |
2016-05-03 |
Yale University |
Cell-free tissue engineered vascular grafts
|
JP6378170B2
(en)
|
2012-04-12 |
2018-08-22 |
イェール ユニバーシティーYale University |
Vehicle for controlled delivery of different pharmaceuticals
|
US9597385B2
(en)
|
2012-04-23 |
2017-03-21 |
Allertein Therapeutics, Llc |
Nanoparticles for treatment of allergy
|
WO2013184976A2
(en)
|
2012-06-06 |
2013-12-12 |
Northwestern University |
Compositions and methods for antigen-specific tolerance
|
AU2013278056B2
(en)
|
2012-06-21 |
2018-07-05 |
Northwestern University |
Peptide conjugated particles
|
CA2921491C
(en)
|
2012-08-23 |
2022-06-21 |
Susan Marie Metcalfe |
Neurotherapeutic nanoparticle compositions and devices
|
KR20160014584A
(en)
|
2013-03-13 |
2016-02-11 |
코어 파마슈티칼스 디벨롭먼트 컴퍼니 |
Immune-modifying particles for the treatment of inflammation
|
AU2014248090B2
(en)
|
2013-04-03 |
2018-08-02 |
N-Fold Llc |
Novel nanoparticle compositions
|
ES2762187T3
(en)
|
2013-08-13 |
2020-05-22 |
Univ Northwestern |
Peptide-conjugated particles
|
US20160228521A1
(en)
|
2013-09-16 |
2016-08-11 |
Allertein Therapeutics, Llc |
Managing immune responses in transplantation
|
CA2987519A1
(en)
|
2013-11-01 |
2015-05-07 |
Yale University |
Delivery vehicles
|
US10898593B2
(en)
|
2014-05-13 |
2021-01-26 |
Yale University |
Compositions for nanoconfinement induced contrast enhancement and methods of making and using thereof
|
WO2016057909A1
(en)
|
2014-10-10 |
2016-04-14 |
Cour Pharmaceuticals Development Company |
Immune-modifying particles for the treatment of ebola virus
|
IL293655A
(en)
|
2015-05-27 |
2022-08-01 |
Univ Northwestern |
Carbohydrate-modified particles and particulate formulations for modulating an immune response
|
WO2017075053A1
(en)
|
2015-10-26 |
2017-05-04 |
Cour Pharmaceuticals Development Company Inc. |
Immune-modifying particles for the treatment of malaria
|
CA3008892A1
(en)
|
2015-12-23 |
2017-06-29 |
Cour Pharmaceuticals Development Company Inc. |
Covalent polymer-antigen conjugated particles
|
JP6904959B2
(en)
|
2016-01-04 |
2021-07-21 |
クール ファーマシューティカルズ ディベロップメント カンパニー インコーポレイテッド |
Particles encapsulating a fusion protein containing a binding epitope
|
WO2017139498A1
(en)
|
2016-02-09 |
2017-08-17 |
Cour Pharmaceuticals Development Company Inc. |
Timps encapsulating japanese cedar pollen epitopes
|
US11484506B2
(en)
|
2016-02-18 |
2022-11-01 |
Cour Pharmaceuticals Development Company, Inc. |
Process for the preparation of tolerizing immune-modulating particles
|